In view of PI3K inhibitors were determined that could reverse TKIs resistance in tumor 73, and activated AKT promoting TKIs resistance in RCC 74, we speculate that MIR503HG-KO cells will be more sensitive to those TKIs than control cells. Here, AKT1 is linked to neoplasm.